TDOC Stock Chart & Stats
$105.19
-$1.33(-0.86%)
At close: 4:00 PM EDT
$105.19
-$1.33(-0.86%)
Day’s Range― - ―
52-Week Range$78.00 - $170.00
Previous CloseN/A
Volume162.00
Average Volume (3M)2.74K
Market Cap
$29.14B
Enterprise Value$1.24B
Total Cash (Recent Filing)$849.91M
Total Debt (Recent Filing)$1.03B
Price to Earnings (P/E)―
Beta0.51
Next Earnings
Feb 23, 2027EPS Estimate
-2.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.86
Shares Outstanding181,684,020
10 Day Avg. Volume8,078
30 Day Avg. Volume2,743
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.89
Price to Sales (P/S)0.49
P/FCF Ratio4.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$153.89Price Target Upside46.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)-16.87
Revenue Forecast (FY)$45.42B
Bulls Say, Bears Say
Bulls Say
Recurring Cash GenerationConsistently positive operating and free cash flow gives Teladoc internal funding capacity despite reported losses. This supports investment in products, debt management, and operations while reducing reliance on external capital over the next several quarters.
Integrated Care Growth And MarginsIntegrated Care combines modest revenue growth with strong and expanding profitability, indicating improving economics in a core business area. Membership scale, chronic-care adoption, and international growth can support durable contribution as the segment develops.
Platform ExpansionExpanding from virtual technology into hospital and health-system clinical services broadens Teladoc’s addressable market. New AI workflow tools may also improve operating efficiency and strengthen the platform’s usefulness across care settings.
Bears Say
BetterHelp Revenue DeclinePersistent declines in BetterHelp revenue and paying users weaken consolidated growth and create pressure on the company’s largest consumer-facing business. Insurance expansion is progressing, but management still expects cash-pay weakness to remain a material headwind.
Continued Net LossesTeladoc’s improving EBITDA and cash generation have not yet translated into accounting profitability. Continued net losses constrain retained capital, limit financial flexibility, and leave the company dependent on sustained operating improvement to strengthen long-term returns.
Convertible Debt MaturityThe upcoming $1 billion maturity is a significant capital-allocation obligation relative to the company’s cash profile. Refinancing or repayment could consume liquidity, add financing costs, or constrain investment while management continues to repair profitability.
Teladoc News
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was $78.00 and its highest was $170.00 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $29.14B.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Feb 23, 2027 which is in 115 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Oct 28, 2026. The company reported -$2.818 earnings per share for the quarter, beating the consensus estimate of -$4.077 by $1.259.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -2.07.
How many shares outstanding does Teladoc have?
Teladoc has 181,684,020 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$2.818 in its last earnings report, beating expectations of -$4.077. Following the earnings report the stock price went up 30.952%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in MX:TDOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$153.89 (46.30% Upside)
$153.89 (46.30% Upside)
Blogger Sentiment
Bullish
MX:TDOC Sentiment 69%
Sector Average 64%
Sector Average 64%
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.63%
12-Months-Change
Fundamentals
Return on Equity
-11.63%
Trailing 12-Months
Asset Growth
-3.59%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Teladoc
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
TDOC Company Deck
TDOC Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was positive overall. Management reported a solid third quarter with adjusted EBITDA above guidance, expanding margins, strong cash flow and liquidity, improved leverage, Integrated Care growth, and accelerating BetterHelp insurance traction. These positives outweighed the ongoing BetterHelp cash pay decline, lower total revenue and paying users, margin pressure, and continued uncertainty around the business transition.View all MX:TDOC earnings summariesTDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$153.89
▲(46.30% Upside)
Technical Analysis
American Well
―
Doximity
―
VSee Health
―
Hinge Health, Inc. Class A
―
Omada Health, Inc.
―